Tuesday, March 18th, 2025 - Day 1 Main ConferenceTuesday, 18 March 2025 - EST/EDT (Eastern Daylight, GMT-4)

Explore the transformative dynamics shaping healthcare coverage and access in 2025, with a special focus on the most pressing trends and issues that are set to redefine the industry.

• Gauge the impact of the November 2024 election on the direction of health policy at the federal level, especially as it relates to the Inflation Reduction Act and Affordable Care Act

• Gain insights into the evolving regulatory environment, including updates on the Part D benefit redesign and rollout of the Medicare Prescription Payment Plan

• Assess the continued prevalence of payer and employer models restricting the use of manufacturer-sponsored financial assistance

• Discuss potential policy solutions and strategies to address the barriers to healthcare access

• Contrast U.S. trends with European policy updates, examining how Europe addresses affordability, access, and regulatory changes

In fall 2024, the PAN Foundation conducted national polling that illuminated a sobering statistic: 87% of Medicare beneficiaries had not seen, read or heard anything about the Medicare Part D reforms to take effect January 1, 2025. The PAN Foundation has since led a national education effort to shift that statistic—and subsequently polled people with Medicare again in 2025 to measure the impact of educational outreach. In this session:

• Gain access to new research and insights on the current state of awareness among Medicare beneficiaries of the Part D cap and Medicare Prescription Payment Plan and the role of education in shifting that awareness

• Learn more about national educational efforts intended to increase awareness, knowledge and ultimately, patients’ ability to make empowered decisions around their healthcare

• Discuss practical strategies to ensure patients know about these reforms, increase health literacy and provide access to high quality and culturally competent health information

• Explore challenges associated with the Medicare Prescription Payment Plan that may impact their successful implementation

Diagnosed with Lupus in 2004, Shanelle has dedicated her life to raising awareness, amplifying patient voices and pushing for greater diversity in healthcare. With spoken word and musical performances from global stages like Lincoln Center to the Vatican and advocacy work spanning from Capitol Hill to clinical trial awareness, Shanelle brings a unique perspective to the patient experience. As a member of the Lupus Voices Council and a celebrated artist, Shanelle shares her powerful journey of resilience, creativity and the role of art in patient engagement.

In this exclusive roundtable, industry leaders will dive deep into how patient access needs are being assessed and the critical role affordability plays in shaping healthcare decisions. With a focus on real-world strategies and emerging trends, explore how data-driven insights are informing policy, operational changes and innovative approaches to patient support.

Join a dynamic panel of clinical, copay, PAP and pharmacy experts from Cardinal Health Sonexus™ Access and Patient Support as they explore how we can better support today’s patient in an increasingly complex ecosystem. Through an interactive discussion and live audience polling, we’ll address key challenges that patients face in accessing and navigating support services. We invite you to participate, share your perspectives, and collaborate with experts to shape the future of patient assistance.

The Evolution of Patient Assistance Programs — Adapting to a Dynamic Landscape

In a rapidly changing healthcare environment, the evolution of PAPs are essential for meeting the growing needs of patients. This session dives into the ways PAPs are becoming more agile and responsive, integrating advanced technology and financial services to provide holistic support.

• Explore strategies for adapting to new market constraints, prioritizing the patients who need assistance the most and making tough decisions about resource allocation, including how teams are engaging with their board and donors

• Gain insights into how PAPs are navigating these challenges while staying true to their mission of ensuring access to essential therapies

In a constantly evolving landscape, hear directly from U.S. Department of Justice leadership on recent policy changes impacting corporate enforcement and compliance, the most recent and impactful cases impacting bio/pharmaceutical manufacturers on areas of focus related to patient assistance and free drug programs and where they are heading next.

In a rapidly changing healthcare environment, the evolution of PAPs are essential for meeting the growing needs of patients while containing program costs, but are PAPs keeping pace with the evolving landscape? The legal and compliance guardrails of free goods programs cause organizations to deprioritize the investment resulting in a lag in program innovation. Although we must operate PAPs compliantly the impact of a free goods programs on the overall brand success can not be decoupled from the stakeholder experience. This session explores the growing need for PAPs to become more agile and responsive, integrating advanced technology and financial services to provide holistic support while being mindful of the overall stakeholder experience.